Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dihydroquinazolinone compound or pharmacologically acceptable salt, and cell growth inhibitor

Dihydroquinazolinone compound or pharmacologically acceptable salt, and cell growth inhibitor

US Patent 11566017 · Granted Jan 31, 2023

Estimated economic value: $586,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compound or pharmaceutically acceptable salt thereof2022
Compound or pharmaceutically acceptable salt thereof2022
Compound or pharmaceutically acceptable salt thereof2022
Compound or pharmaceutically acceptable salt thereof2022
Compound or pharmaceutically acceptable salt thereof2022
Compound or pharmaceutically acceptable salt thereof2022
Biomarkers, test method, and test kit for predicting therapeutic effect of anti-2022
Pyridine derivative2021
Pyridine derivative2019
Pyridine derivative2018
Pyridine derivatives2018
Nitrogen-containing bicyclic aromatic heterocyclic compound2017